Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ferozsons Laboratories Ltd.

www.ferozsons-labs.com

Latest From Ferozsons Laboratories Ltd.

Zydus Cadila Plans Indian Remdesivir Entry In July

Zydus Cadila hopes to launch its version of Gilead’s remdesivir by end-July in India, even as earlier licensees Hetero Drugs and Cipla have just commercialized the antiviral. Plans for pegylated interferon alfa-2b to treat COVID-19 include a trial in Mexico and an IND in the US. Separately, desidustat is being considered for additional indications.

Strategy Generic Drugs

Is Dexamethasone The Next Hydroxychloroquine For India?

While the jury is still out on dexamethasone being the new hero in the fight against COVID-19 after the hype around hydroxychloroquine has died down, Indian pharma is watching developments closely. Gains of companies like Zydus Cadila, Wockhardt, Cadila and Cipla in the domestic market will be constrained by price caps while any increase in exports will depend on emergency use authorizations.

Coronavirus COVID-19 India

Gilead Licenses Remdesivir To Five Firms

Gilead has announced a raft of licensing agreements with five generics firms to manufacture potential COVID-19 treatment remdesivir for distribution in 127 countries.

Deals Intellectual Property
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pakistan
  • Parent & Subsidiaries
  • Ferozsons Laboratories Ltd.
  • Senior Management
  • Osman Khalid Waheed, Pres.
  • Contact Info
  • Ferozsons Laboratories Ltd.
    Phone: (92) 51 556 2155
    197-A, The Mall
    Rawalpindi, 46000
    Pakistan
UsernamePublicRestriction

Register